Search

everythinglearnresearchcommunity

for

Search:↓

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

Telogen effluvium is a hair loss condition that can be treated with medications like minoxidil.

Better understanding and new treatments for hidradenitis suppurativa are emerging, but more research is needed.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Science and technology are rapidly advancing and impacting various aspects of life in Ukraine.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

COVID-19 may cause hair loss due to infection stress or treatments.

Women with high androgen levels may have more severe COVID-19 symptoms.

Public interest in COVID-19-related hair loss increased during COVID-19 surges, especially with the omicron variant.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

COVID-19 may trigger alopecia areata, but more research is needed.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Post-COVID-19 hair loss can be treated effectively with therapies like light therapy, microneedling, and scalp massage.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Thyroid function may influence hair loss after COVID-19.

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

Systemic retinoids do not increase COVID-19 risk or severity.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.